Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers

被引:32
作者
Gilani, K
Najafabadi, AR [1 ]
Barghi, M
Rafiee-Tehrani, M
机构
[1] Univ Tehran Med Sci, Sch Pharm, Aerosol Res Lab, Tehran, Iran
[2] Univ Tehran, Sch Sci, XRD Res Lab, Tehran, Iran
[3] Univ Tehran, Sch Sci, XRD Res Lab, Tehran, Iran
关键词
aerosolisation; spray drying; dry powder inhaler; fine particle fraction; beclomethasone dipropionate; lactose; polyethylene glycols; crystallinity;
D O I
10.1016/j.ejpb.2004.04.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to characterize the physical properties of spray dried lactose in the presence of different polyethylene glycols (PEG 400, PEG 3000 and PEG 6000) and to evaluate their performance as carriers for dry powder inhaler (DPI) formulations. The efficiency of spray dried lactose/PEG carriers in aerosolisation of beclomethasone dipropionate (BD), a model hydrophobic drug, was compared to Pharmatose(TM) 325 M (L325), spray dried lactose alone (SDL), and also a sieved (< 38 mum) fraction of alpha-lactose monohydrate (SL). In vitro deposition analysis was performed using a twin stage liquid impinger at a flow rate of 60 l/min through a Spinhaler((R)). The deposition profiles of the drug from binary formulations composed of BD and spray dried lactose/PEG carriers were also compared to ternary formulations containing large and fine lactose carriers. Differential scanning calorimetry and X-ray diffraction data showed the presence of a-anhydrous lactose in spray dried lactose/PEG crystalline powders. Spray drying of lactose in the presence of PEG 400 resulted in the production of a powder (SDL-PEG400) with lower a-lactose, monohydrate content, and also smaller particle size distribution than those obtained in the presence of PEG 3000 (SDL-PEG3000) or PEG 6000 (SDL-PEG6000). All formulations showed different deposition profiles, except those containing SDL-PEG3000 or SDL-PEG6000 which exhibited similar data. The fine particle fraction of aerosolised BD varied from 6.26 +/- 1.07 (for L325) to 25.87 +/- 5.33 (for SDL-PEG3000). All deposition profiles of BD aerosolised from SDL-PEG3000 were significantly higher (P < 0.01) than those produced by binary and ternary formulations containing L325, a coarse lactose commercially available for DPI formulations. The differences observed in deposition data for various carriers were interpreted according to their physical properties. It was concluded that particle size distribution, morphology and specific surface texture of SDL-PEG3000 and SDL-PEG6000 were important factors influencing their efficiency as small carriers for DPI formulations. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 29 条
[1]   LACTOSE AND THERMAL-ANALYSIS WITH SPECIAL EMPHASIS ON MICROCALORIMETRY [J].
ANGBERG, M .
THERMOCHIMICA ACTA, 1995, 248 :161-176
[2]  
Bennett F., 1996, European Journal of Pharmaceutical Sciences, V4, pS66, DOI 10.1016/S0928-0987(97)86226-4
[3]   Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger [J].
Braun, MA ;
Oschmann, R ;
Schmidt, PC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) :53-62
[4]   PHYSICAL CHARACTERIZATION OF PHARMACEUTICAL SOLIDS [J].
BRITTAIN, HG ;
BOGDANOWICH, SJ ;
BUGAY, DE ;
DEVINCENTIS, J ;
LEWEN, G ;
NEWMAN, AW .
PHARMACEUTICAL RESEARCH, 1991, 8 (08) :963-973
[5]   SOME FUTURE PERSPECTIVES FOR UNIT DOSE INHALATION AEROSOLS [J].
BYRON, PR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (07) :993-1015
[6]   Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations [J].
Chan, LW ;
Lim, LT ;
Heng, PWS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :975-984
[7]   The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose [J].
Chidavaenzi, OC ;
Buckton, G ;
Koosha, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 216 (1-2) :43-49
[8]   The use of thermal techniques to assess the impact of feed concentration on the amorphous content and polymorphic forms present in spray dried lactose [J].
Chidavaenzi, OC ;
Buckton, G ;
Koosha, F ;
Pathak, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 159 (01) :67-74
[9]   THE USE OF AMORPHOUS MODEL SUBSTANCES TO STUDY MECHANICALLY ACTIVATED MATERIALS IN THE SOLID-STATE [J].
ELAMIN, AA ;
SEBHATU, T ;
AHLNECK, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (01) :25-36
[10]  
GANDERTON D, 1992, ADV PHARM SCI, V6, P165